Biopharma Overview

Optimizing R&D efficiency for biopharma

Pharmaceutical and biotechnology companies are caught today between rising development costs and shrinking margins. Factors such as blockbuster patent expirations, increasing generic competition, and a tightening of the regulatory environment make it imperative to enhance R&D productivity to better meet the medical needs of the 21st century.

From molecular target identification to clinical trials, biopharma is fueled by information. Process that information faster and communicate it more effectively, and you are positioned to enhance innovation and create a more efficient and profitable business. Although tremendous advances have been made, the lack of integrated digital information in biopharma reduces innovation, drives up costs, hinders efficiency, and slows time-to-market.

Intel is passionate about the potential of information technology to drive innovation and improve efficiency in biopharma R&D. We connect people and information in new ways that can transform workflows and increase innovation and flexibility on both the scientific and operational sides of your life science business.

Through our platforms and experience-driving technology advances, integrating technologies and architectures, sharing best practices—we help pharmaceutical companies, medical research centers, and biotech innovators to:

• Accelerate scientific research and innovation
• Optimize clinical trials
• Reduce total cost of ownership and increase enterprise agility